Invictus RG’s Tandem Diabetes Care TNDM Stock Holding History

Invictus RG’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,400	Closed	-$336K	–	29
2020 Q2	$336K	Buy	+3,400	New	+$271K	5.5%	10

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Invictus RG's TNDM Position: Q3 2020 in Review

Invictus RG sold out of Tandem Diabetes Care (TNDM) in Q3 2020, closing a stake of 3,400 shares — an estimated $336K sold.

Invictus RG first reported a position in TNDM in Q2 2020 and held it in 1 quarter. The position peaked at $336K in Q2 2020. 321 funds tracked by Wall St. Rank hold TNDM as of Q3 2020.

Invictus RG reported no remaining Tandem Diabetes Care position as of Q3 2020 after selling out during the quarter.
Invictus RG sold 3,400 Tandem Diabetes Care shares in Q3 2020, an estimated $336K.
Invictus RG first reported a position in Tandem Diabetes Care in Q2 2020 and held it in 1 quarter.
Invictus RG's Tandem Diabetes Care position peaked at $336K in Q2 2020.
321 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2020.

Based on Invictus RG's 13F filing for Q3 2020, filed 13 Nov 2020.